Search

everythinglearnresearchcommunity

for

Search:↓

Children's hairlines change shape as they grow, with women often developing a widow's peak and men's hairlines becoming more convex and possibly balding at the temples, influenced by genetics and hormones.

Dihydrotestosterone (DHT) is crucial for conditions like male-pattern baldness and acne, and measuring a byproduct, androstanediol glucuronide, is a better way to assess DHT's effects than DHT blood levels.

SMP creates illusion of full hair, addressing various issues and bringing happiness to those with thinning hair.

FUE and SMP together can effectively treat hair loss, needing fewer procedures.

New drug shows promise for better hair growth in baldness treatment.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Scalp micropigmentation, a cosmetic tattoo technique, is a promising non-surgical treatment for hair and scalp deformities, despite potential complications.

SMP is a medical tattoo for hair loss, improving appearance and camouflaging scars, but requires skill and has limitations.

The study found genetic differences related to hair development that may explain hair loss in a patient with Trichorhinophalangeal syndrome type I.

SFRP2 and PTGDS may be key factors in female hair loss.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Balding men had lower bone density, while balding women had higher hip bone density.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Male-pattern baldness might be caused by the effect of hormones on scalp blood vessels.

Power-enhancing drugs can cause mood swings, aggression, anxiety, and physical side effects, questioning their overall benefits.

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

A mutation in mice causes hair loss and immune problems.

New genes found linked to balding, may help develop future treatments.

No genetic link between prostaglandins and hair loss found.

The research suggests that SFRP2 and PTGDS proteins might be indicators of female pattern hair loss and could contribute to hair loss.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Brothers of women with PCOS tend to have higher levels of a hormone called DHEAS, indicating a possible genetic link.

A mutation in mice causes hair loss and skin issues due to a defect in a gene affecting cell adhesion.

Androgenetic alopecia is a condition causing noticeable hair loss, especially in middle age, which is more severe than normal balding.

Early balding in men might be a male hormonal equivalent of polycystic ovaries syndrome in women.

Balding scalps show different gene expressions affecting hair growth compared to non-balding scalps.

Androgens affect hair growth and shedding, with genetic and non-genetic factors influencing baldness.

Balding people may have higher heart disease risk.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.